{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "9517619", "DateCompleted": {"Year": "1998", "Month": "04", "Day": "07"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1073-449X", "JournalIssue": {"Volume": "157", "Issue": "3 Pt 1", "PubDate": {"Year": "1998", "Month": "Mar"}}, "Title": "American journal of respiratory and critical care medicine", "ISOAbbreviation": "Am J Respir Crit Care Med"}, "ArticleTitle": "Proliferation of airway epithelium after ozone exposure: effect of apocynin and dexamethasone.", "Pagination": {"StartPage": "970", "EndPage": "977", "MedlinePgn": "970-7"}, "Abstract": {"AbstractText": ["Ozone is an environmental pollutant with potent oxidizing properties. We investigated whether exposure to ozone-induced cell proliferation in the lungs of rats, and determined the effect of an antioxidant and of a glucocorticosteroid in Brown-Norway (BN) rats. Following single ozone exposure (0.5, 1.0, or 3.0 ppm for 6 h), proliferating cell nuclear antigen (PCNA) expression, as determined with immunohistochemistry, was significantly increased in the bronchial epithelium and alveolar epithelium as compared with controls exposed to filtered air with a maximal effect at 24 to 48 h (p < 0.001). Apocynin (5 mg/kg, orally), a reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, reduced the PCNA index in bronchial epithelium induced by ozone (3 ppm, 6 h) from 11.5 +/- 1.3% (percent of nuclear cells expressing PCNA) to 4.4 +/- 1.3% (mean +/- SEM; p < 0.05). Dexamethasone (3 mg/kg, intraperitoneally) also reduced the PCNA index in bronchial epithelium, from 19.2 +/- 2.3% to 10.9 +/- 2.6% (p < 0.05). Dexamethasone but not apocynin inhibited ozone-induced neutrophil influx. Rats exposed repeatedly to ozone (3.0 ppm, 3 h, on three occasions 48 h apart) expressed a lower PCNA index in bronchial epithelium than did rats exposed only once at 1.9 +/- 0.7% versus 6.0 +/- 0.9%, respectively (p < 0.05). The proliferative epithelial response following a single exposure to ozone is modulated through oxidative and inflammatory mechanisms probably involving neutrophils."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, United Kingdom."}], "Identifier": [], "LastName": "Salmon", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Koto", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lynch", "ForeName": "O T", "Initials": "OT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Haddad", "ForeName": "E B", "Initials": "EB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lamb", "ForeName": "N J", "Initials": "NJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Quinlan", "ForeName": "G J", "Initials": "GJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Barnes", "ForeName": "P J", "Initials": "PJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "K F", "Initials": "KF"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Crit Care Med", "NlmUniqueID": "9421642", "ISSNLinking": "1073-449X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Acetophenones"}, {"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucocorticoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Proliferating Cell Nuclear Antigen"}, {"RegistryNumber": "53-59-8", "NameOfSubstance": "NADP"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7S5I7G3JQL", "NameOfSubstance": "Dexamethasone"}, {"RegistryNumber": "B6J7B9UDTR", "NameOfSubstance": "acetovanillone"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Acetophenones"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Bronchi"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["drug effects"], "DescriptorName": "Chemotaxis, Leukocyte"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Dexamethasone"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Epithelium"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Glucocorticoids"}, {"QualifierName": [], "DescriptorName": "Immunohistochemistry"}, {"QualifierName": [], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Injections, Intraperitoneal"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "NADP"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["analysis", "genetics"], "DescriptorName": "Proliferating Cell Nuclear Antigen"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Pulmonary Alveoli"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Inbred BN"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "3", "Day": "28"}, {"Year": "1998", "Month": "3", "Day": "28", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "3", "Day": "28", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9517619", "10.1164/ajrccm.157.3.9704067"]}}], "PubmedBookArticle": []}